- Rating
- 2
- Confidence
- 2
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 1
Read review
Paper summary
This paper proposes DualRE-Surv for multimodal cancer survival prediction. It combines representation-level fusion with an evidence-aware path that decomposes modality evidence into consensus and complementary components. Experiments on eight TCGA cohorts show improved C-index over existing methods.
Critical strengths
- The paper addresses an interesting problem of conflicting predictions across modalities.
- The experiments are relatively comprehensive, including eight datasets, ablations, and robustness analyses.
Critical weaknesses
My main concern is the methodological soundness. The method directly converts survival logits into Dirichlet evidence and interprets the resulting vacuity as predictive uncertainty. However, survival risk and predictive confidence are fundamentally different concepts. Unlike standard EDL, the method does not use an explicit evidential learning objective or validate uncertainty calibration. This questionable assumption undermines the foundation of the entire evidence-aware fusion mechanism.
Questions for authors
- How can survival logits be interpreted as evidence of predictive confidence? If the unimodal logits represent conditional hazards, then the proposed vacuity satisfies: . This makes vacuity a deterministic function of predicted survival probability rather than an independent uncertainty estimate. Could the authors clarify the unimodal logits and justify this design, preferably with uncertainty calibration experiments?
- Related prior work (M2EF-NNs[1]) has already explored Dirichlet-based uncertainty estimation and decision-level evidence fusion for multimodal cancer survival prediction. Although it is briefly mentioned in Related Work, the paper does not clearly explain how the proposed evidence fusion differs from or improves upon this closely related method. A direct experimental comparison is also missing.
[1]Luo, Hui, et al. "Multimodal multi-instance evidence fusion neural networks for cancer survival prediction." Scientific Reports 15.1 (2025): 10470.